stoxline Quote Chart Rank Option Currency Glossary
  
Park Ha Biological Technology Co., Ltd. (PHH)
14.56  0.03 (0.21%)    05-22 16:00
Open: 14.39
High: 16
Volume: 382,462
  
Pre. Close: 14.53
Low: 13.89
Market Cap: 384(M)
Technical analysis
2025-05-22 3:49:58 PM
Short term     
Mid term     
Targets 6-month :  17.31 1-year :  19.34
Resists First :  14.82 Second :  16.55
Pivot price 13.99
Supports First :  12.02 Second :  10
MAs MA(5) :  14.4 MA(20) :  14.03
MA(100) :  0 MA(250) :  0
MACD MACD :  0.4 Signal :  0.4
%K %D K(14,3) :  62.1 D(3) :  63.6
RSI RSI(14): 54.3
52-week High :  16.55 Low :  3.92
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PHH ] has closed below upper band by 38.9%. Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 15.02 - 15.08 15.08 - 15.14
Low: 12.88 - 12.94 12.94 - 12.99
Close: 14.42 - 14.53 14.53 - 14.63
Company Description

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Headline News

Wed, 30 Apr 2025
Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 - Yahoo Finance

Tue, 29 Apr 2025
Why These 15 Consumer Defensive Stocks Are Surging in 2025 - Insider Monkey

Mon, 31 Mar 2025
Park Ha Biological Technology: Growth Potential And Profitability Concerns (NASDAQ:PHH) - Seeking Alpha

Tue, 25 Mar 2025
Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? - Yahoo Finance

Mon, 30 Dec 2024
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering - GlobeNewswire

Thu, 26 Dec 2024
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Consumer Defensive
Industry:
Household & Personal Products
Shares Out 26 (M)
Shares Float 5 (M)
Held by Insiders 81.7 (%)
Held by Institutions 0.3 (%)
Shares Short 118 (K)
Shares Short P.Month 8 (K)
Stock Financials
EPS 0.01
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.05
Profit Margin 20 %
Operating Margin 45.8 %
Return on Assets (ttm) 18.5 %
Return on Equity (ttm) 38 %
Qtrly Rev. Growth 40.5 %
Gross Profit (p.s.) 0.08
Sales Per Share 0.09
EBITDA (p.s.) 0.03
Qtrly Earnings Growth 22.1 %
Operating Cash Flow 1 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 713.5
PEG Ratio 0
Price to Book value 237.83
Price to Sales 158.1
Price to Cash Flow 391.78
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android